Granite Point Capital Management, L.P. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 65 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$374,000
-70.1%
43,000
-57.0%
0.04%
-70.7%
Q4 2017$1,252,000
-25.1%
100,000
-50.0%
0.12%
-65.1%
Q3 2017$1,672,000
-27.1%
200,000
+47.9%
0.35%
-37.8%
Q2 2017$2,294,000
+15.3%
135,200
+36.6%
0.57%
-4.9%
Q1 2017$1,990,00099,0000.60%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders